BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23733180)

  • 1. Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione.
    Chatterjee S; Chakraborty P; Banerjee K; Sinha A; Adhikary A; Das T; Choudhuri SK
    Biometals; 2013 Jun; 26(3):517-34. PubMed ID: 23733180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K; Biswas MK; Choudhuri SK
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
    Ghosh RD; Banerjee K; Das S; Ganguly A; Chakraborty P; Sarkar A; Chatterjee M; Choudhuri SK
    Eur J Pharm Sci; 2013 Jul; 49(4):737-47. PubMed ID: 23665413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response.
    Chakraborty P; Das S; Banerjee K; Sinha A; Roy S; Chatterjee M; Choudhuri SK
    Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):165-75. PubMed ID: 24611750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate.
    Chakraborty P; Chatterjee S; Ganguly A; Saha P; Adhikary A; Das T; Chatterjee M; Choudhuri SK
    J Leukoc Biol; 2012 Apr; 91(4):609-19. PubMed ID: 22279179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular interaction of a copper chelate with human P-glycoprotein.
    Ghosh RD; Chakraborty P; Banerjee K; Adhikary A; Sarkar A; Chatterjee M; Das T; Choudhuri SK
    Mol Cell Biochem; 2012 May; 364(1-2):309-20. PubMed ID: 22258826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
    Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
    BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
    Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
    Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
    Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.
    Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK
    Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells.
    Chatterjee S; Mookerjee A; Basu JM; Chakraborty P; Ganguly A; Adhikary A; Mukhopadhyay D; Ganguly S; Banerjee R; Ashraf M; Biswas J; Das PK; Sa G; Chatterjee M; Das T; Choudhuri SK
    PLoS One; 2009 Sep; 4(9):e7048. PubMed ID: 19756150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of a cytotoxic 2-substituted benzimidazole copper(II) complex: DNA damage, antiproliferation and apoptotic induction activity in human cervical cancer cells.
    Qiao X; Ma ZY; Shao J; Bao WG; Xu JY; Qiang ZY; Lou JS
    Biometals; 2014 Feb; 27(1):155-72. PubMed ID: 24368745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
    Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
    Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory Activity of the Copper Chelate, Copper N-(2-Hydroxy Acetophenone) Glycinate, in ABC-transporter-expressing Cell Lines.
    Hartinger EM; Mahringer A; Choudhuri SK; Fricker G; Efferth T
    Anticancer Res; 2023 Mar; 43(3):1031-1041. PubMed ID: 36854510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.